Skip to main content
Erschienen in: Inflammopharmacology 6/2023

04.11.2023 | Review

Targeting memory loss with aspirin, a molecular mechanism perspective for future therapeutic approaches

verfasst von: Masoumeh Gholami, Mehdi Sadegh, Masoumeh Koroush-arami, Shaghayegh Norouzi, Rasoul Jafari Arismani, Erfan Asadi, Mohammad Amini, Nahid Khodayari

Erschienen in: Inflammopharmacology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Acetylsalicylic acid (ASA), also known as aspirin, was discovered in 1897 as an acetylated form of salicylate. It has been widely used for its anti-inflammatory and antiplatelet effects. It is commonly used for its cardiovascular benefits and is prescribed as secondary prophylaxis after a heart attack. Furthermore, low-dose, long-term ASA is used to reduce the risk of heart attack and stroke in individuals without prior cardiovascular disease. Acetylsalicylic acid acts as a non-selective inhibitor of cyclooxygenase (COX), which inhibits the synthesis of prostaglandins and prevents pro-inflammatory cytokines. Findings suggest that targeting cytokines and growth factors could be a potential therapeutic strategy for reducing neuroinflammation and slowing down the progression of dementia. Additionally, prostaglandins contribute to synaptic plasticity and can act as retrograde messengers in synapses. Research has implicated COX-1, one of the isoforms of the enzyme, in neuroinflammation and neurodegenerative disorders. The inhibition of COX-1 might potentially prevent impairments in working memory and reduce neuroinflammation caused by beta-amyloid proteins in some conditions, such as Alzheimer’s disease (AD). Cyclooxygenase-2, an inducible form of the enzyme, is expressed in cortical and hippocampal neurons and is associated with long-term synaptic plasticity. The inhibition or knockout of COX-2 has been shown to decrease long-term potentiation, a process involved in memory formation. Studies have also demonstrated that the administration of COX-2 inhibitors impairs cognitive function and memory acquisition and recall in animal models. There remains a debate regarding the effects of aspirin on dementia and cognitive decline. Although some studies suggest a possible protective effect of non-steroidal anti-inflammatory drugs, including aspirin, against the development of AD, others have shown inconsistent evidence. This review provides an overview of the effects of ASA or its active metabolite salicylate on learning, memory, and synaptic plasticity.
Literatur
Zurück zum Zitat Akaneya Y, Tsumoto T (2006) Bidirectional trafficking of prostaglandin E2 receptors involved in long-term potentiation in visual cortex. J Neurosci 26(40):10209–10221 PubMedPubMedCentralCrossRef Akaneya Y, Tsumoto T (2006) Bidirectional trafficking of prostaglandin E2 receptors involved in long-term potentiation in visual cortex. J Neurosci 26(40):10209–10221 PubMedPubMedCentralCrossRef
Zurück zum Zitat Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2(10):734–744 PubMedCrossRef Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2(10):734–744 PubMedCrossRef
Zurück zum Zitat Al-Sofiani ME, Derenbecker R, Quartuccio M, Kalyani RR (2019) Aspirin for primary prevention of cardiovascular disease in diabetes: a review of the evidence. Curr DiabRep 19:1–10 Al-Sofiani ME, Derenbecker R, Quartuccio M, Kalyani RR (2019) Aspirin for primary prevention of cardiovascular disease in diabetes: a review of the evidence. Curr DiabRep 19:1–10
Zurück zum Zitat Amann R, Peskar BA (2002) Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol 447(1):1–9 PubMedCrossRef Amann R, Peskar BA (2002) Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol 447(1):1–9 PubMedCrossRef
Zurück zum Zitat An C, Mou Z (2011) Salicylic acid and its function in plant immunity F. J Integr Plant Biol 53(6):412–428 PubMedCrossRef An C, Mou Z (2011) Salicylic acid and its function in plant immunity F. J Integr Plant Biol 53(6):412–428 PubMedCrossRef
Zurück zum Zitat Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N (2001) Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76(6):1895–1904 PubMedCrossRef Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N (2001) Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76(6):1895–1904 PubMedCrossRef
Zurück zum Zitat Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13(7):826–834 PubMedCrossRef Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13(7):826–834 PubMedCrossRef
Zurück zum Zitat Bahniwal M, Little JP, Klegeris A (2017) High glucose enhances neurotoxicity and inflammatory cytokine secretion by stimulated human astrocytes. Curr Alzheimer Res 14(7):731–741 PubMedCrossRef Bahniwal M, Little JP, Klegeris A (2017) High glucose enhances neurotoxicity and inflammatory cytokine secretion by stimulated human astrocytes. Curr Alzheimer Res 14(7):731–741 PubMedCrossRef
Zurück zum Zitat Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR (2000) Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci 97(18):10272–10276 PubMedPubMedCentralCrossRef Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR (2000) Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci 97(18):10272–10276 PubMedPubMedCentralCrossRef
Zurück zum Zitat Bergström P, Agholme L, Nazir FH, Satir TM, Toombs J, Wellington H, Strandberg J, Bontell TO, Kvartsberg H, Holmström M, Boreström C (2016) Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation. Sci Rep 6(1):29200 PubMedPubMedCentralCrossRef Bergström P, Agholme L, Nazir FH, Satir TM, Toombs J, Wellington H, Strandberg J, Bontell TO, Kvartsberg H, Holmström M, Boreström C (2016) Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation. Sci Rep 6(1):29200 PubMedPubMedCentralCrossRef
Zurück zum Zitat Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O’Neil A, Davey CG, Sanna L, Maes M (2013) Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med 11(1):1–17 CrossRef Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O’Neil A, Davey CG, Sanna L, Maes M (2013) Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med 11(1):1–17 CrossRef
Zurück zum Zitat Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhäuser C, Pilati E, Volterra A (2004) Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7(6):613–620 PubMedCrossRef Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhäuser C, Pilati E, Volterra A (2004) Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7(6):613–620 PubMedCrossRef
Zurück zum Zitat Bosetti F, Langenbach R, Weerasinghe GR (2004) Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2. J Neurochem 91(6):1389–1397 PubMedCrossRef Bosetti F, Langenbach R, Weerasinghe GR (2004) Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2. J Neurochem 91(6):1389–1397 PubMedCrossRef
Zurück zum Zitat Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Readhead B, Dudley JT, Spangenberg EE, Green KN, Belfiore R (2017) Necroptosis activation in Alzheimer’s disease. Nat Neurosci 20(9):1236–1246 PubMedCrossRef Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Readhead B, Dudley JT, Spangenberg EE, Green KN, Belfiore R (2017) Necroptosis activation in Alzheimer’s disease. Nat Neurosci 20(9):1236–1246 PubMedCrossRef
Zurück zum Zitat Chandra S, Jana M, Pahan K (2018) Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of Alzheimer’s disease via PPARα. J Neurosci 38(30):6682–6699 PubMedPubMedCentralCrossRef Chandra S, Jana M, Pahan K (2018) Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of Alzheimer’s disease via PPARα. J Neurosci 38(30):6682–6699 PubMedPubMedCentralCrossRef
Zurück zum Zitat Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14:450–464 PubMedCrossRef Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14:450–464 PubMedCrossRef
Zurück zum Zitat Chen C, Bazan NG (2005a) Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J Neurophysiol 93(2):929–941 PubMedCrossRef Chen C, Bazan NG (2005a) Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J Neurophysiol 93(2):929–941 PubMedCrossRef
Zurück zum Zitat Chen C, Bazan NG (2005b) Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat 77(1–4):65–76 PubMedCrossRef Chen C, Bazan NG (2005b) Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat 77(1–4):65–76 PubMedCrossRef
Zurück zum Zitat Chen C, Magee JC, Bazan NG (2002) Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J Neurophysiol 87(6):2851–2857 PubMedCrossRef Chen C, Magee JC, Bazan NG (2002) Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J Neurophysiol 87(6):2851–2857 PubMedCrossRef
Zurück zum Zitat Chen S, Yang J, Wei Y, Wei X (2020) Epigenetic regulation of macrophages: from homeostasis maintenance to host defense. Cell Mol Immunol 17(1):36–49 PubMedCrossRef Chen S, Yang J, Wei Y, Wei X (2020) Epigenetic regulation of macrophages: from homeostasis maintenance to host defense. Cell Mol Immunol 17(1):36–49 PubMedCrossRef
Zurück zum Zitat Choi SH, Langenbach R, Bosetti F (2008) Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J 22(5):1491–1501 PubMedCrossRef Choi SH, Langenbach R, Bosetti F (2008) Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J 22(5):1491–1501 PubMedCrossRef
Zurück zum Zitat Choi S-H, Aid S, Bosetti F (2009) The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 30(4):174–181 PubMedPubMedCentralCrossRef Choi S-H, Aid S, Bosetti F (2009) The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 30(4):174–181 PubMedPubMedCentralCrossRef
Zurück zum Zitat Chuang D-M, Hough C, Senatorov VV (2005) Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45:269–290 PubMedCrossRef Chuang D-M, Hough C, Senatorov VV (2005) Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45:269–290 PubMedCrossRef
Zurück zum Zitat Davis KA, Bishara D, Molokhia M, Mueller C, Perera G, Stewart RJ (2021) Aspirin in people with dementia, long-term benefits, and harms: a systematic review. Eur J Clin Pharmacol 77:943–954 PubMedPubMedCentralCrossRef Davis KA, Bishara D, Molokhia M, Mueller C, Perera G, Stewart RJ (2021) Aspirin in people with dementia, long-term benefits, and harms: a systematic review. Eur J Clin Pharmacol 77:943–954 PubMedPubMedCentralCrossRef
Zurück zum Zitat Di Filippo M, Sarchielli P, Picconi B, Calabresi P (2008) Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29(8):402–412 PubMedCrossRef Di Filippo M, Sarchielli P, Picconi B, Calabresi P (2008) Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29(8):402–412 PubMedCrossRef
Zurück zum Zitat Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, Chen JX (2010) RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease. FASEB J 24(4):1043 PubMedPubMedCentralCrossRef Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, Chen JX (2010) RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease. FASEB J 24(4):1043 PubMedPubMedCentralCrossRef
Zurück zum Zitat Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement 10(1):S76–S83 PubMed Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement 10(1):S76–S83 PubMed
Zurück zum Zitat Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE (1990) Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8(1):303–333 PubMedCrossRef Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE (1990) Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8(1):303–333 PubMedCrossRef
Zurück zum Zitat Förstl H, Levy R (1991) On certain peculiar diseases of old age. Hist Psychiatry 2:71–101 PubMedCrossRef Förstl H, Levy R (1991) On certain peculiar diseases of old age. Hist Psychiatry 2:71–101 PubMedCrossRef
Zurück zum Zitat Gilroy DW (2005) The role of aspirin-triggered lipoxins in the mechanism of action of aspirin. Prostaglandins Leukot Essent Fatty Acids 73(3–4):203–210 PubMedCrossRef Gilroy DW (2005) The role of aspirin-triggered lipoxins in the mechanism of action of aspirin. Prostaglandins Leukot Essent Fatty Acids 73(3–4):203–210 PubMedCrossRef
Zurück zum Zitat Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Investig 116(1):4–15 PubMedPubMedCentralCrossRef Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Investig 116(1):4–15 PubMedPubMedCentralCrossRef
Zurück zum Zitat Guan P-P, Ding W-Y, Wang P (2022) Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons. Front Mol Neurosci 15:1006216 PubMedPubMedCentralCrossRef Guan P-P, Ding W-Y, Wang P (2022) Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons. Front Mol Neurosci 15:1006216 PubMedPubMedCentralCrossRef
Zurück zum Zitat Hampel H, Caraci F, Cuello AC, Caruso G, Nisticò R, Corbo M, Baldacci F, Toschi N, Garaci F, Chiesa PA, Verdooner SR (2020) A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease. Front Immunol 11:456 PubMedPubMedCentralCrossRef Hampel H, Caraci F, Cuello AC, Caruso G, Nisticò R, Corbo M, Baldacci F, Toschi N, Garaci F, Chiesa PA, Verdooner SR (2020) A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease. Front Immunol 11:456 PubMedPubMedCentralCrossRef
Zurück zum Zitat Harris RE, Beebe-Donk J, Doss H, Doss DB (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol Rep 13(4):559–583 PubMed Harris RE, Beebe-Donk J, Doss H, Doss DB (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol Rep 13(4):559–583 PubMed
Zurück zum Zitat Harrison SL, Ding J, Tang EY, Siervo M, Robinson L, Jagger C, Stephan BC (2014) Cardiovascular disease risk models and longitudinal changes in cognition: a systematic review. PLoS ONE 9(12):e114431 PubMedPubMedCentralCrossRef Harrison SL, Ding J, Tang EY, Siervo M, Robinson L, Jagger C, Stephan BC (2014) Cardiovascular disease risk models and longitudinal changes in cognition: a systematic review. PLoS ONE 9(12):e114431 PubMedPubMedCentralCrossRef
Zurück zum Zitat Hemmer B, Archelos JJ, Hartung H-P (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3(4):291–301 PubMedCrossRef Hemmer B, Archelos JJ, Hartung H-P (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3(4):291–301 PubMedCrossRef
Zurück zum Zitat Hölscher C (1995) Inhibitors of cyclooxygenases produce amnesia for a passive avoidance task in the chick. Eur J Neurosci 7(6):1360–1365 PubMedCrossRef Hölscher C (1995) Inhibitors of cyclooxygenases produce amnesia for a passive avoidance task in the chick. Eur J Neurosci 7(6):1360–1365 PubMedCrossRef
Zurück zum Zitat Huber SJ, Shuttleworth EC, Paulson GW, Bellchambers MJ, Clapp LE (1986) Cortical vs subcortical dementia: neuropsychological differences. Arch Neurol 43(4):392–394 PubMedCrossRef Huber SJ, Shuttleworth EC, Paulson GW, Bellchambers MJ, Clapp LE (1986) Cortical vs subcortical dementia: neuropsychological differences. Arch Neurol 43(4):392–394 PubMedCrossRef
Zurück zum Zitat Leglera DF, Brucknera M, Uetz-von Allmena E, Krausea (2010) Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 42(2):198–201 CrossRef Leglera DF, Brucknera M, Uetz-von Allmena E, Krausea (2010) Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 42(2):198–201 CrossRef
Zurück zum Zitat Li H, Li W, Zhang X, Ma X-C, Zhang R-W (2021) Aspirin use on incident dementia and mild cognitive decline: a systematic review and meta-analysis. Front Aging Neurosci 12:578071 PubMedPubMedCentralCrossRef Li H, Li W, Zhang X, Ma X-C, Zhang R-W (2021) Aspirin use on incident dementia and mild cognitive decline: a systematic review and meta-analysis. Front Aging Neurosci 12:578071 PubMedPubMedCentralCrossRef
Zurück zum Zitat Maher F, Nolan Y, Lynch MA (2005) Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol Aging 26(5):717–728 PubMedCrossRef Maher F, Nolan Y, Lynch MA (2005) Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol Aging 26(5):717–728 PubMedCrossRef
Zurück zum Zitat Marquis-Gravel G, Roe MT, Harrington RA, Muñoz D, Hernandez AF, Jones WS (2019) Revisiting the role of aspirin for the primary prevention of cardiovascular disease. Circulation 140(13):1115–1124 PubMedCrossRef Marquis-Gravel G, Roe MT, Harrington RA, Muñoz D, Hernandez AF, Jones WS (2019) Revisiting the role of aspirin for the primary prevention of cardiovascular disease. Circulation 140(13):1115–1124 PubMedCrossRef
Zurück zum Zitat Medala VK, Gollapelli B, Dewanjee S, Ogunmokun G, Kandimalla R, Vallamkondu J (2021) Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer’s disease. J Neurosci Res 99(4):1120–1135 PubMedCrossRef Medala VK, Gollapelli B, Dewanjee S, Ogunmokun G, Kandimalla R, Vallamkondu J (2021) Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer’s disease. J Neurosci Res 99(4):1120–1135 PubMedCrossRef
Zurück zum Zitat Medeiros R, Kitazawa M, Passos GF, Baglietto-Vargas D, Cheng D, Cribbs DH, LaFerla FM (2013) Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease–like pathology in mice. Am J Pathol 182(5):1780–1789 PubMedPubMedCentralCrossRef Medeiros R, Kitazawa M, Passos GF, Baglietto-Vargas D, Cheng D, Cribbs DH, LaFerla FM (2013) Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease–like pathology in mice. Am J Pathol 182(5):1780–1789 PubMedPubMedCentralCrossRef
Zurück zum Zitat Melo HM (2019) Potential effects of aspirin on lysosomal biogenesis and amyloid-β clearance: an old drug and novel insights in alzheimer’s disease therapy. J Neurosci 39(2):197–198 PubMedPubMedCentralCrossRef Melo HM (2019) Potential effects of aspirin on lysosomal biogenesis and amyloid-β clearance: an old drug and novel insights in alzheimer’s disease therapy. J Neurosci 39(2):197–198 PubMedPubMedCentralCrossRef
Zurück zum Zitat Menon PK, Koistinen NA, Iverfeldt K, Ström A-L (2019) Phosphorylation of the amyloid precursor protein (APP) at Ser-675 promotes APP processing involving meprin β. J Biol Chem 294(47):17768–17776 PubMedPubMedCentralCrossRef Menon PK, Koistinen NA, Iverfeldt K, Ström A-L (2019) Phosphorylation of the amyloid precursor protein (APP) at Ser-675 promotes APP processing involving meprin β. J Biol Chem 294(47):17768–17776 PubMedPubMedCentralCrossRef
Zurück zum Zitat Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63(9):901–910 PubMedCrossRef Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63(9):901–910 PubMedCrossRef
Zurück zum Zitat Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI (2015) The 12 years preceding mild cognitive impairment due to Alzheimer’s disease: the temporal emergence of cognitive decline. J Alzheimers Dis 48(4):1095–1107 PubMedPubMedCentralCrossRef Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI (2015) The 12 years preceding mild cognitive impairment due to Alzheimer’s disease: the temporal emergence of cognitive decline. J Alzheimers Dis 48(4):1095–1107 PubMedPubMedCentralCrossRef
Zurück zum Zitat Murray H, O’Connor J (2003) A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro. Neuropharmacology 44(3):374–380 PubMedCrossRef Murray H, O’Connor J (2003) A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro. Neuropharmacology 44(3):374–380 PubMedCrossRef
Zurück zum Zitat Naka H, Nomura E, Kitamura J, Imamura E, Wakabayashi S, Matsumoto M (2013) Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents. J Stroke Cerebrovasc Dis 22(6):834–840 PubMedCrossRef Naka H, Nomura E, Kitamura J, Imamura E, Wakabayashi S, Matsumoto M (2013) Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents. J Stroke Cerebrovasc Dis 22(6):834–840 PubMedCrossRef
Zurück zum Zitat Nguyen TN, Chen LJ, Trares K, Stocker H, Holleczek B, Beyreuther K, Brenner H, Schöttker B (2022) Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies. Alzheimer’s Res Ther 14(1):75 CrossRef Nguyen TN, Chen LJ, Trares K, Stocker H, Holleczek B, Beyreuther K, Brenner H, Schöttker B (2022) Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies. Alzheimer’s Res Ther 14(1):75 CrossRef
Zurück zum Zitat Niikura T, Tajima H, Kita Y (2006) Neuronal cell death in Alzheimer’s disease and a neuroprotective factor, humanin. Curr Neuropharmacol 4(2):139–147 PubMedPubMedCentralCrossRef Niikura T, Tajima H, Kita Y (2006) Neuronal cell death in Alzheimer’s disease and a neuroprotective factor, humanin. Curr Neuropharmacol 4(2):139–147 PubMedPubMedCentralCrossRef
Zurück zum Zitat Ogunmokun G, Dewanjee S, Chakraborty P, Valupadas C, Chaudhary A, Kolli V, Anand U, Vallamkondu J, Goel P, Paluru HP, Gill KD (2021) The potential role of cytokines and growth factors in the pathogenesis of Alzheimer’s disease. Cells 10(10):2790 PubMedPubMedCentralCrossRef Ogunmokun G, Dewanjee S, Chakraborty P, Valupadas C, Chaudhary A, Kolli V, Anand U, Vallamkondu J, Goel P, Paluru HP, Gill KD (2021) The potential role of cytokines and growth factors in the pathogenesis of Alzheimer’s disease. Cells 10(10):2790 PubMedPubMedCentralCrossRef
Zurück zum Zitat Patel D, Roy A, Kundu M, Jana M, Luan C-H, Gonzalez FJ, Pahan K (2018) Aspirin binds to PPARα to stimulate hippocampal plasticity and protect memory. Proc Natl Acad Sci 115(31):E7408–E7417 PubMedPubMedCentralCrossRef Patel D, Roy A, Kundu M, Jana M, Luan C-H, Gonzalez FJ, Pahan K (2018) Aspirin binds to PPARα to stimulate hippocampal plasticity and protect memory. Proc Natl Acad Sci 115(31):E7408–E7417 PubMedPubMedCentralCrossRef
Zurück zum Zitat Patrono C (2015) The multifaceted clinical readouts of platelet inhibition by low-dose aspirin. J Am Coll Cardiol 66(1):74–85 PubMedCrossRef Patrono C (2015) The multifaceted clinical readouts of platelet inhibition by low-dose aspirin. J Am Coll Cardiol 66(1):74–85 PubMedCrossRef
Zurück zum Zitat Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J (2010) Cognitive and functional decline in Huntington’s disease: dementia criteria revisited. Mov Disord 25(9):1163–1169 PubMedPubMedCentralCrossRef Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J (2010) Cognitive and functional decline in Huntington’s disease: dementia criteria revisited. Mov Disord 25(9):1163–1169 PubMedPubMedCentralCrossRef
Zurück zum Zitat Rall JM, Mach SA, Dash PK (2003) Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res 968(2):273–276 PubMedCrossRef Rall JM, Mach SA, Dash PK (2003) Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res 968(2):273–276 PubMedCrossRef
Zurück zum Zitat Rivera-Escalera F, Pinney JJ, Owlett L, Ahmed H, Thakar J, Olschowka JA, Elliott MR, O’Banion MK (2019) IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia. J Neuroinflammation 16:1–17 CrossRef Rivera-Escalera F, Pinney JJ, Owlett L, Ahmed H, Thakar J, Olschowka JA, Elliott MR, O’Banion MK (2019) IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia. J Neuroinflammation 16:1–17 CrossRef
Zurück zum Zitat Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, Propson NE, Xu Y, Jankowsky JL, Liu Z, Lee VM (2020) Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Investig 130(4):1912–1930 PubMedPubMedCentralCrossRef Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, Propson NE, Xu Y, Jankowsky JL, Liu Z, Lee VM (2020) Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Investig 130(4):1912–1930 PubMedPubMedCentralCrossRef
Zurück zum Zitat Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, Nelson MR, Chong TT, Williamson JD, Ward SA, Lockery JE (2020) Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology 95(3):e320–e331 PubMedPubMedCentralCrossRef Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, Nelson MR, Chong TT, Williamson JD, Ward SA, Lockery JE (2020) Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology 95(3):e320–e331 PubMedPubMedCentralCrossRef
Zurück zum Zitat Sang N, Chen C (2006) Lipid signaling and synaptic plasticity. Neuroscientist 12(5):425–434 PubMedCrossRef Sang N, Chen C (2006) Lipid signaling and synaptic plasticity. Neuroscientist 12(5):425–434 PubMedCrossRef
Zurück zum Zitat Sang N, Zhang J, Marcheselli V, Bazan NG, Chen C (2005) Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J Neurosci 25(43):9858–9870 PubMedPubMedCentralCrossRef Sang N, Zhang J, Marcheselli V, Bazan NG, Chen C (2005) Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J Neurosci 25(43):9858–9870 PubMedPubMedCentralCrossRef
Zurück zum Zitat Sato T, Ishida T, Irifune M, Tanaka K-I, Hirate K, Nakamura N, Nishikawa T (2007) Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice. Eur J Pharmacol 560(1):36–41 PubMedCrossRef Sato T, Ishida T, Irifune M, Tanaka K-I, Hirate K, Nakamura N, Nishikawa T (2007) Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice. Eur J Pharmacol 560(1):36–41 PubMedCrossRef
Zurück zum Zitat Sezgin M, Bilgic B, Tinaz S, Emre M (2019) Parkinson’s disease dementia and Lewy body disease. Semin Neurol 39:274–282 PubMedCrossRef Sezgin M, Bilgic B, Tinaz S, Emre M (2019) Parkinson’s disease dementia and Lewy body disease. Semin Neurol 39:274–282 PubMedCrossRef
Zurück zum Zitat Sharifzadeh M, Tavasoli M, Soodi M, Mohammadi-Eraghi S, Ghahremani MH, Roghani A (2006) A time course analysis of cyclooxygenase-2 suggests a role in spatial memory retrieval in rats. Neurosci Res 54(3):171–179 PubMedCrossRef Sharifzadeh M, Tavasoli M, Soodi M, Mohammadi-Eraghi S, Ghahremani MH, Roghani A (2006) A time course analysis of cyclooxygenase-2 suggests a role in spatial memory retrieval in rats. Neurosci Res 54(3):171–179 PubMedCrossRef
Zurück zum Zitat Shaw KN, Commins S, O’Mara SM (2003) Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor. Eur J Neurosci 17(11):2438–2446 PubMedCrossRef Shaw KN, Commins S, O’Mara SM (2003) Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor. Eur J Neurosci 17(11):2438–2446 PubMedCrossRef
Zurück zum Zitat Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56(3):387–437 PubMedCrossRef Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56(3):387–437 PubMedCrossRef
Zurück zum Zitat Suresh J, Khor IW, Kaur P, Heng HL, Torta F, Dawe GS, Tai ES, Tolwinski NS (2021) Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches. FEBS J 288(12):3855–3873 PubMedCrossRef Suresh J, Khor IW, Kaur P, Heng HL, Torta F, Dawe GS, Tai ES, Tolwinski NS (2021) Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches. FEBS J 288(12):3855–3873 PubMedCrossRef
Zurück zum Zitat Tachida Y, Nakagawa K, Saito T, Saido TC, Honda T, Saito Y, Murayama S, Endo T, Sakaguchi G, Kato A, Kitazume S (2008) Interleukin-1β up-regulates TACE to enhance α-cleavage of APP in neurons: resulting decrease in Aβ production. J Neurochem 104(5):1387–1393 PubMedCrossRef Tachida Y, Nakagawa K, Saito T, Saido TC, Honda T, Saito Y, Murayama S, Endo T, Sakaguchi G, Kato A, Kitazume S (2008) Interleukin-1β up-regulates TACE to enhance α-cleavage of APP in neurons: resulting decrease in Aβ production. J Neurochem 104(5):1387–1393 PubMedCrossRef
Zurück zum Zitat Teeling J, Cunningham C, Newman TA, Perry V (2010) The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun 24(3):409–419 PubMedPubMedCentralCrossRef Teeling J, Cunningham C, Newman TA, Perry V (2010) The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun 24(3):409–419 PubMedPubMedCentralCrossRef
Zurück zum Zitat Thal DR, Griffin WST, Braak H (2008) Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer’s disease. J Cell Mol Med 12(5b):1848–1862 PubMedPubMedCentralCrossRef Thal DR, Griffin WST, Braak H (2008) Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer’s disease. J Cell Mol Med 12(5b):1848–1862 PubMedPubMedCentralCrossRef
Zurück zum Zitat Tortosa E, Avila J, Pérez M (2006) Acetylsalicylic acid decreases tau phosphorylation at serine 422. Neurosci Lett 396(1):77–80 PubMedCrossRef Tortosa E, Avila J, Pérez M (2006) Acetylsalicylic acid decreases tau phosphorylation at serine 422. Neurosci Lett 396(1):77–80 PubMedCrossRef
Zurück zum Zitat Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235 PubMedCrossRef Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235 PubMedCrossRef
Zurück zum Zitat Vane JR, Botting RM (1998) Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104(3S1):2S-8S PubMedCrossRef Vane JR, Botting RM (1998) Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104(3S1):2S-8S PubMedCrossRef
Zurück zum Zitat Vilček J, Feldmann M (2004) Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 25(4):201–209 PubMedCrossRef Vilček J, Feldmann M (2004) Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 25(4):201–209 PubMedCrossRef
Zurück zum Zitat Vital Trial Collaborative Group (2003) Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 254(1):67–75 CrossRef Vital Trial Collaborative Group (2003) Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 254(1):67–75 CrossRef
Zurück zum Zitat Voilley N (2004) Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs). Curr Drug Targets Inflamm Allergy 3(1):71–79 PubMedCrossRef Voilley N (2004) Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs). Curr Drug Targets Inflamm Allergy 3(1):71–79 PubMedCrossRef
Zurück zum Zitat Voilley N, de Weille J, Mamet J, Lazdunski M (2001) Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21(20):8026–8033 PubMedPubMedCentralCrossRef Voilley N, de Weille J, Mamet J, Lazdunski M (2001) Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21(20):8026–8033 PubMedPubMedCentralCrossRef
Zurück zum Zitat Wang YP, Wu Y, Li LY, Zheng J, Liu RG, Zhou JP, Yuan SY, Shang Y, Yao SL (2011) Aspirin-triggered lipoxin A4attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells. J Neuroinflammation 8(1):1–12 CrossRef Wang YP, Wu Y, Li LY, Zheng J, Liu RG, Zhou JP, Yuan SY, Shang Y, Yao SL (2011) Aspirin-triggered lipoxin A4attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells. J Neuroinflammation 8(1):1–12 CrossRef
Zurück zum Zitat Wang W, Ye SD, Zhou KQ, Wu LM, Huang YN (2012) High doses of salicylate and aspirin are inhibitory on acid-sensing ion channels and protective against acidosis-induced neuronal injury in the rat cortical neuron. J Neurosci Res 90(1):267–277 PubMedCrossRef Wang W, Ye SD, Zhou KQ, Wu LM, Huang YN (2012) High doses of salicylate and aspirin are inhibitory on acid-sensing ion channels and protective against acidosis-induced neuronal injury in the rat cortical neuron. J Neurosci Res 90(1):267–277 PubMedCrossRef
Zurück zum Zitat Wemmie JA, Chen J, Askwith CC, Hruska-Hageman AM, Price MP, Nolan BC, Yoder PG, Lamani E, Hoshi T, Freeman JH, Welsh MJ (2002) The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory. Neuron 34(3):463–477 PubMedCrossRef Wemmie JA, Chen J, Askwith CC, Hruska-Hageman AM, Price MP, Nolan BC, Yoder PG, Lamani E, Hoshi T, Freeman JH, Welsh MJ (2002) The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory. Neuron 34(3):463–477 PubMedCrossRef
Zurück zum Zitat Weng J, Zhao G, Weng L, Guan J, Initiative ASDN (2021) Aspirin using was associated with slower cognitive decline in patients with Alzheimer’s disease. PLoS ONE 16(6):e0252969 PubMedPubMedCentralCrossRef Weng J, Zhao G, Weng L, Guan J, Initiative ASDN (2021) Aspirin using was associated with slower cognitive decline in patients with Alzheimer’s disease. PLoS ONE 16(6):e0252969 PubMedPubMedCentralCrossRef
Zurück zum Zitat World Health Organization (2019) Risk reduction of cognitive decline and dementia: WHO guidelines. World Health Organization, Geneva World Health Organization (2019) Risk reduction of cognitive decline and dementia: WHO guidelines. World Health Organization, Geneva
Zurück zum Zitat Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11(2):371–386 PubMedCrossRef Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11(2):371–386 PubMedCrossRef
Zurück zum Zitat Yang H, Zhang J, Andreasson K, Chen C (2008) COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity. Mol Cell Neurosci 37(4):682–695 PubMedPubMedCentralCrossRef Yang H, Zhang J, Andreasson K, Chen C (2008) COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity. Mol Cell Neurosci 37(4):682–695 PubMedPubMedCentralCrossRef
Zurück zum Zitat Yermakova AV, Rollins J, Callahan LM, Rogers J, O’Banion MK (1999) Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J Neuropathol Exp Neurol 58(11):1135–1146 PubMedCrossRef Yermakova AV, Rollins J, Callahan LM, Rogers J, O’Banion MK (1999) Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J Neuropathol Exp Neurol 58(11):1135–1146 PubMedCrossRef
Zurück zum Zitat Zheng SL, Roddick AJ (2019) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA 321(3):277–287 PubMedPubMedCentralCrossRef Zheng SL, Roddick AJ (2019) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA 321(3):277–287 PubMedPubMedCentralCrossRef
Zurück zum Zitat Zhu P, Genc A, Zhang X, Zhang J, Bazan NG, Chen C (2005) Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors. J Neurosci Res 81(6):817–826 PubMedCrossRef Zhu P, Genc A, Zhang X, Zhang J, Bazan NG, Chen C (2005) Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors. J Neurosci Res 81(6):817–826 PubMedCrossRef
Metadaten
Titel
Targeting memory loss with aspirin, a molecular mechanism perspective for future therapeutic approaches
verfasst von
Masoumeh Gholami
Mehdi Sadegh
Masoumeh Koroush-arami
Shaghayegh Norouzi
Rasoul Jafari Arismani
Erfan Asadi
Mohammad Amini
Nahid Khodayari
Publikationsdatum
04.11.2023
Verlag
Springer International Publishing
Erschienen in
Inflammopharmacology / Ausgabe 6/2023
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-023-01347-1

Weitere Artikel der Ausgabe 6/2023

Inflammopharmacology 6/2023 Zur Ausgabe